Can COVID-19 have a clinically significant effect on drug metabolism?

Taylor and Francis Group, Expert Opinion on Drug Safety, 1(22), p. 1-3, 2023

Journal article published in 2023 by Felicia Ceban

, Mehala Subramaniapillai, Joshua D. Rosenblat, Rodrigo B. Mansur, Roger S. McIntyre

Distributing this paper is prohibited by the publisher

Full text: Unavailable

Preprint: archiving forbidden

Postprint: archiving restricted

Upload

Published version: archiving forbidden

Policy details

Data provided by